EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document C:2015:095:TOC
Official Journal of the European Union, C 95, 21 March 2015
Official Journal of the European Union, C 95, 21 March 2015
Official Journal of the European Union, C 95, 21 March 2015
ISSN 1977-091X |
||
Official Journal of the European Union |
C 95 |
|
English edition |
Information and Notices |
Volume 58 |
Notice No |
Contents |
page |
|
II Information |
|
|
INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
European Commission |
|
2015/C 095/01 |
Guidelines of 19 March 2015 on principles of Good Distribution Practice of active substances for medicinal products for human use ( 1 ) |
1 |
2015/C 095/02 |
Guidelines of 19 March 2015 on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use ( 1 ) |
10 |
2015/C 095/03 |
Non-opposition to a notified concentration (Case M.7275 — Novartis/GlaxoSmithKline Oncology Business) ( 1 ) |
14 |
2015/C 095/04 |
Non-opposition to a notified concentration (Case M.7496 — Panasonic/Ficosa Inversion/Ficosa International) ( 1 ) |
14 |
2015/C 095/05 |
15 |
|
IV Notices |
|
|
NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
|
|
Council |
|
2015/C 095/06 |
17 |
|
2015/C 095/07 |
18 |
|
|
European Commission |
|
2015/C 095/08 |
19 |
|
2015/C 095/09 |
20 |
|
|
European Investment Fund |
|
2015/C 095/10 |
22 |
|
V Announcements |
|
|
PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
|
|
European Commission |
|
2015/C 095/11 |
Prior notification of a concentration (Case M.7526 — G.L. Swarovski/Bilfinger/ProfiCare) — Candidate case for simplified procedure ( 1 ) |
32 |
|
OTHER ACTS |
|
|
European Commission |
|
2015/C 095/12 |
33 |
|
|
|
(1) Text with EEA relevance |
EN |
|